Advertisement

PharmacoEconomics & Outcomes News

, Volume 813, Issue 1, pp 32–32 | Cite as

Tyrosine kinase inhibitors cost effective for CML

Clinical study

Reference

  1. Fu J, et al. Economic Evaluations of Tyrosine Kinase Inhibitors for Patients with Chronic Myeloid Leukemia in Middle- and High-Income Countries: A Systematic Review. Clinical Drug Investigation : 19 Sep 2018. Available from: URL: http://doi.org/10.1007/s40261-018-0706-5

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations